Protein Supplement for Frailty in Heart Surgery Patients
(PROTECT-CS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine whether a protein supplement can aid frail patients in recovering more effectively after heart surgery. Frail patients often struggle with longer recovery times and may lose some independence post-surgery. The trial will compare a special protein drink, ISOlution protein supplement, with a placebo (a lookalike drink with no nutritional benefit) to assess its impact on recovery. The study seeks participants aged 60 and older who are awaiting specific types of heart surgery and feel less strong or energetic than before. As an unphased trial, it offers a unique opportunity to contribute to research that may enhance recovery for future heart surgery patients.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that protein supplements can be safe and beneficial for older adults, particularly those who are frail. For example, one study found that increasing protein intake, especially with leucine-enriched whey protein, improved heart health when combined with exercise. This is significant because frailty and muscle loss are common in older patients undergoing heart surgery.
Another study found that whey protein helps maintain muscle mass and strength, which is crucial for heart patients who often experience muscle loss. These studies reported no major side effects, suggesting that the ISOlution protein supplement is well-tolerated. While these results are promising, individuals should always consult their doctor before starting any new supplement, especially if they have existing health conditions.12345Why are researchers excited about this trial?
Researchers are excited about the ISOlution protein supplement because it takes a fresh approach to tackling frailty in heart surgery patients. Unlike current treatments that primarily focus on medications and physical rehabilitation, this supplement provides a leucine-rich protein boost, helping to boost muscle strength and recovery. By delivering essential amino acids directly through a dietary supplement, it offers a potentially quicker and more effective way to support recovery and improve outcomes for these patients. This nutritional intervention could change the game by enhancing patients' resilience and recovery speed during the critical pre- and post-surgery phases.
What evidence suggests that the ISOlution protein supplement could be effective for frailty in heart surgery patients?
This trial will compare the effects of a leucine-rich protein supplement with a placebo in frail heart surgery patients. Research has shown that protein supplements can aid frail patients in recovering better after heart surgery. Studies have found that high-protein nutrition can reduce the risk of death in very sick patients. Additionally, taking protein-rich supplements for 12 weeks has been linked to improved muscle mass and strength. This is crucial because frail patients often have weak muscles, which can slow their recovery. Although a definitive study is not yet available, these findings suggest that protein supplements might help frail heart surgery patients regain strength and recover faster.36789
Who Is on the Research Team?
Rakesh Arora, BKin,MD,PhD
Principal Investigator
University of Manitoba
Are You a Good Fit for This Trial?
This trial is for patients aged 60 or older who are frail and waiting for non-emergency heart surgery. They must be able to drink by mouth, speak/read English or French, have a Clinical Frailty Score of 3-6, and an SPPB score ≤9 or SF-36 (PF) score ≤60. Excluded are those with severe cognitive impairment, kidney issues, liver cirrhosis, milk protein allergies, or very severe symptoms.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-surgery Nutrition
Participants receive carbohydrate supplements to help with nausea symptoms, glycemic control, and GI function, and leucine-rich protein supplements for up to 2 weeks prior to surgery.
Post-operative Recovery
Participants receive leucine-rich protein supplements during post-operative recovery in the hospital.
Post-discharge Nutrition
Participants continue to receive leucine-rich protein supplements for 8 weeks following hospital discharge.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 2 and 6 months post-surgery.
What Are the Treatments Tested in This Trial?
Interventions
- ISOlution protein supplement
- Placebo Supplement
Find a Clinic Near You
Who Is Running the Clinical Trial?
St. Boniface Hospital
Lead Sponsor
Heart and Stroke Foundation of Canada
Collaborator